top of page

FBB at The Parkinson's Solution Summit 2.0

FBB's CEO Dr. Urnovitz was invited to talk about the link between Parkinson's disease and virology. How do ancestral viruses, inherited from our parents, play a critical role in disease initiation and progression? What does this imply for patient outcomes? Watch the video to find out.

Review a FBB Test results report

Contact us for a sample test results report (Research Use Only)

Discern your patients' state of health with precision

Differentiate between multiple neurologic health states with a single blood test (Research Use Only). Discover the precision enabled by measuring chronically expressed RNA.

​

Then help your patients in achieving health and vitality by tracking their ancestral gene expression through our blood test alternative to the spinal tap (lumbar puncture).

Clinical study launched

Monitor ancestral gene activity to be among the first to focus on the cause, not the effect.

​

Our discovery enables you to compare your patients' genomic profiles with our proprietary database and track disease-related genomic biomarkers. All through a simple blood test.

How it works 

1

Patient gives a blood sample

2

Our lab processes the sample securely

3

Receive the patient's personalized report

4

Meet your patient to interpret their test results 

Peer-reviewed publications
 

1999 Paper: HIV Urine Antibodies

FBB's CEO built a test based on ancestral genes to detect asymptomatic silent carriers: "Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection"

1996 Paper: Endogenous Retroviruses

FBB's CEO published the landmark review of the role of a subgroup of EANS in human disease: "Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease"

1980 Paper: Co-Infections

Co-infection by lactic dehydrogenase virus and C-type retrovirus elicits neurological disease

​

2023 Poster (P015)

Chronically Expressed Blood-Borne Endogenous Ancestral Nucleotide Sequences RNA of Patients with Multiple Sclerosis, Alzheimer’s, or Parkinson’s Disease are Biomarkers for Differential Diagnosis and Monitoring

2022 Poster (P048)

Newly Discovered Blood RNA Biomarkers in Relapsing Remitting Multiple Sclerosis Patients are Expressed Higher than in Patients with Alzheimer’s Disease, Parkinson’s Disease, or Amyotrophic Lateral Sclerosis

2020 Poster (P142)

RNA Differential Expression In Serial Blood Samples Of Relapsing Remitting Multiple Sclerosis Patients Correlates With Clinically Reported Flares

​

Publications by FBB Biomed:

Publications related to EANS:

Clinical Researcher

Differentiate between multiple neurologic health states

bottom of page